Genomic Testing and New Directions for Treatment
You may have heard of genomic testing, but may not be sure what it is and if it is right for you. Genomic testing is a rapidly growing area of research with potential new directions for breast cancer treatment. Genomic tests look at the level of activity of the genes in the tumor itself to determine how likely the tumors are to grow, spread or respond to treatment.
During this presentation we’ll explain what genomic testing is, how it’s used in breast cancer, where to get it and how to pay for it. We’ll explain how researchers use these tests today and the cutting-edge treatments available, often through clinical trials, based on the information gathered through genomic tests.
This is a test.
Nikhil Wagle, MD
Assistant Professor of Medicine, Harvard Medical School
Medical Oncologist, Dana Farber Cancer Institute
Associate Member, Broad Institute of MIT and Harvard
Dr. Wagle leads a translational research program in the field of breast cancer genomics and precision (or “personalized”) cancer medicine. The major goals of his work are to better understand the biology of metastatic breast cancer and to develop new ways to overcome or prevent medicine resistance in people with advanced breast cancer. Dr. Wagle also leads The Metastatic Breast Cancer Project, mbcproject.org, a nationwide research initiative that seeks to empower people with advanced breast cancer around the U.S. to fast-track cancer research by sharing their tumor samples and clinical information. Read more.
This interactive event will feature a panel discussion followed by a Q&A session. You can attend this free event in person or by live web stream. The program will begin at 6:00 p.m. (ET). For those attending in person, registration and refreshments will begin at 5:30 p.m. (ET). Both in-person and web stream audiences will be able to text their questions to the moderator during the Q&A session.
For questions or to register by phone call toll-free (855) 807-6386.